These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38303526)

  • 1. A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti-tumor Immunotherapy Response to Human Cancers.
    Xu B; Liang J; Fu L; Wei J; Lin J
    Curr Cancer Drug Targets; 2024; 24(8):846-866. PubMed ID: 38303526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 3. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1.
    He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L
    Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
    Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
    Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
    Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
    Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
    [No Abstract]   [Full Text] [Related]  

  • 6. Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma.
    Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Luo Y; Zhu Y
    Future Oncol; 2018 Apr; 14(10):927-936. PubMed ID: 29528250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SLC7A11-AS1/SLC7A11 pair as a ferroptosis-related therapeutic target for hepatocellular carcinoma.
    Yuan X; Wang Y; Jiao S; Gao H; Zhang M; Wang X; Zhou X; Wu C; Bao J
    J Cell Mol Med; 2024 Jul; 28(13):e18496. PubMed ID: 38984939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WD repeat domain 43 as a new predictive indicator and its connection with tumor immune cell infiltration in pan-cancer.
    Yang X; Luo T; Liu Z; Liu J; Yang Z
    Medicine (Baltimore); 2024 Aug; 103(31):e39153. PubMed ID: 39093744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis/disulifidptosis-related gene SLC7A11 predicts prognosis, immune infiltration, and immunotherapy response in hepatocellular carcinoma.
    Pan Y; Zhang Y; Zhu G; Li S
    Asian J Surg; 2024 Jun; 47(6):2726-2728. PubMed ID: 38531741
    [No Abstract]   [Full Text] [Related]  

  • 10. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
    Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
    Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
    Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
    Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
    Wu X; Wang S; Chen K
    Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
    Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
    Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino acid transporter SLC7A11 expression in breast cancer.
    Nath P; Alfarsi LH; El-Ansari R; Masisi BK; Erkan B; Fakroun A; Ellis IO; Rakha EA; Green AR
    Cancer Biol Ther; 2024 Dec; 25(1):2291855. PubMed ID: 38073087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
    Ji Z; Zhang C; Yuan J; He Q; Zhang X; Yang D; Xu N; Chu J
    PLoS One; 2024; 19(4):e0298775. PubMed ID: 38662757
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Wang X; Zhu HQ; Lin SM; Xia BY; Xu B
    Transl Cancer Res; 2024 May; 13(5):2518-2534. PubMed ID: 38881923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
    He D; Zhang X; Tu J
    Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.